Adipose tissue fatty acid metabolism in insulin-resistant men

Aims/hypothesisIncreased NEFA production and concentrations may underlie insulin resistance. We examined systemic and adipose tissue NEFA metabolism in insulin-resistant overweight men (BMI 25–35 kg/m2).MethodsIn a cohort study we examined NEFA concentrations in men in the upper quartile of fasting insulin (n = 124) and in men with fasting insulin below the median (n = 159). In a metabolic study we examined NEFA metabolism in the fasting and postprandial states, in ten insulin-resistant men and ten controls.ResultsIn the cohort study, fasting NEFA concentrations were not significantly different between the two groups (median values: insulin-resistant men, 410 µmol/l; controls, 445 µmol/l). However, triacylglycerol concentrations differed markedly (1.84 vs 1.18 mmol/l respectively, p < 0.001). In the metabolic study, arterial NEFA concentrations again did not differ between groups, whereas triacylglycerol concentrations were significantly higher in insulin-resistant men. Systemic NEFA production and the release of NEFA from subcutaneous adipose tissue, expressed per unit of fat mass, were both reduced in insulin-resistant men compared with controls (fasting values by 32%, p = 0.02, and 44%, p = 0.04 respectively). 3-Hydroxybutyrate concentrations, an index of hepatic fat oxidation and ketogenesis, were lower (p = 0.03).Conclusions/interpretationAdipose tissue NEFA output is not increased (per unit weight of tissue) in insulin resistance. On the contrary, it appears to be suppressed by high fasting insulin concentrations. Alterations in triacylglycerol metabolism are more marked than those in NEFA metabolism and are indicative of altered metabolic partitioning of fatty acids (decreased oxidation, increased esterification) in the liver.

[1]  M. Jensen,et al.  Validation of a new method for determination of free fatty acid turnover. , 1987, The American journal of physiology.

[2]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[3]  L. Groop,et al.  Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. , 1992, The American journal of physiology.

[4]  L. Opie,et al.  Plasma free fatty acid concentrations in obesity. , 1963, The New England journal of medicine.

[5]  S. Coppack,et al.  Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. , 1992, Metabolism: clinical and experimental.

[6]  B. Howard,et al.  Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  R N Bergman,et al.  Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. , 1996, The Journal of clinical investigation.

[8]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[9]  G. Reaven,et al.  Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. , 1981, Metabolism: clinical and experimental.

[10]  F. Karpe,et al.  The in vivo effects of the Pro12Ala PPARγ2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank , 2005, Diabetologia.

[11]  T. Willson,et al.  Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men , 2008, Diabetes.

[12]  J. Simoneau,et al.  Skeletal muscle utilization of free fatty acids in women with visceral obesity. , 1995, The Journal of clinical investigation.

[13]  X. Papademetris,et al.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[14]  R. Unger.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .

[15]  M. Jensen,et al.  Regional postprandial fatty acid metabolism in different obesity phenotypes. , 1999, Diabetes.

[16]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[17]  Fredrik Karpe,et al.  Preferential Uptake of Dietary Fatty Acids in Adipose Tissue and Muscle in the Postprandial Period , 2007, Diabetes.

[18]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[19]  S. Coppack,et al.  Periprandial regulation of lipid metabolism in insulin-treated diabetes mellitus. , 1993, Metabolism: clinical and experimental.

[20]  K. Frayn.  Visceral fat and insulin resistance — causative or correlative? , 2000, British Journal of Nutrition.

[21]  F. Karpe,et al.  The Contribution of Splanchnic Fat to VLDL Triglyceride Is Greater in Insulin-Resistant Than Insulin-Sensitive Men and Women , 2007, Diabetes.

[22]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[23]  D. Porte,et al.  The Interaction of Diabetes and Obesity on the Regulation of Fat Mobilization in Man , 1969, Diabetes.

[24]  Roland Bramlet,et al.  Radioactive and Stable Isotope Tracers in Biomedicine , 1993 .

[25]  G. Reaven,et al.  Reappraisal of the role of insulin in hypertriglyceridemia. , 1974, The American journal of medicine.

[26]  S. Coppack,et al.  Assessment of white adipose tissue metabolism by measurement of arteriovenous differences. , 2001, Methods in molecular biology.

[27]  H. Lebovitz,et al.  Point: visceral adiposity is causally related to insulin resistance. , 2005, Diabetes care.

[28]  S. Coppack,et al.  Postprandial substrate deposition in human forearm and adipose tissues in vivo. , 1990, Clinical science.

[29]  W. Saris,et al.  Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. , 2001, Diabetes.

[30]  M. Jensen,et al.  Counterpoint: visceral adiposity is not causally related to insulin resistance. , 2005, Diabetes care.

[31]  Donald D Hensrud,et al.  Splanchnic lipolysis in human obesity. , 2004, The Journal of clinical investigation.

[32]  S. Klein,et al.  Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans. , 2006, Metabolism: clinical and experimental.

[33]  N. Nurjhan,et al.  Fat metabolism in human obesity. , 1994, The American journal of physiology.

[34]  B. Balkau,et al.  Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans , 2000, European journal of clinical investigation.

[35]  P. Arner,et al.  Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. , 2007, The Journal of clinical endocrinology and metabolism.

[36]  P. Arner.  Catecholamine-induced lipolysis in obesity , 1999, International Journal of Obesity.

[37]  R. J. Whitney,et al.  Methods for the investigation of peripheral blood flow. , 1963, British medical bulletin.

[38]  N. Lassen,et al.  Blood flow through human adipose tissue determined with radioactive xenon. , 1966, Acta physiologica Scandinavica.

[39]  B. Wolffenbuttel,et al.  Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. , 2000, American journal of physiology. Endocrinology and metabolism.